1755-5914

Cardiovascular Therapeutics

Hindawi Limited

View prefix report (10.1111)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 540 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact540 DOIs
2

Add abstracts to 169 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact169 DOIs
3

Deposit reference lists for 98 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact98 DOIs

DOIs for this ISSN

Showing the top 5 of 593 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Relationship between Oxidative Stress and Inflammatory Cytok… (10.1111/j.1755-5922.2010.00218.x)
ORCID
68.17 532
2 REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Fac… (10.1111/j.1755-5922.2010.00171.x)
ORCID
64.66 385
3 Hypolipidemic, Antioxidant, and Antiinflammatory Activities… (10.1111/j.1755-5922.2010.00200.x)
ORCID
63.25 338
4 Ticagrelor: The First Reversibly Binding Oral P2Y<sub>12</su… (10.1111/j.1755-5922.2009.00096.x)
ORCID
61.48 287
5 The Novel Antioxidant Edaravone: From Bench to Bedside (10.1111/j.1527-3466.2008.00041.x)
ORCID
57.63 201
6 Nutraceuticals and Atherosclerosis: Human Trials (10.1111/j.1755-5922.2010.00189.x)
ORCID
55.82 170
7 A Novel Hydrogen Sulfide Prodrug, <scp>SG</scp>1002, Promote… (10.1111/1755-5922.12128)
ORCID
55.44 164
8 Hyperkalemia Associated with Use of Angiotensin‐Converting E… (10.1111/j.1755-5922.2010.00258.x)
ORCID
55.30 162
9 REVIEW: Sodium Channel (Dys)Function and Cardiac Arrhythmias (10.1111/j.1755-5922.2010.00210.x)
ORCID
54.18 146
10 Xanthine Oxidase Inhibition For The Treatment Of Cardiovascu… (10.1111/j.1755-5922.2011.00277.x)
ORCID
53.73 140
11 Natural Antioxidants and Hypertension: Promise and Challenge… (10.1111/j.1755-5922.2010.00137.x)
ORCID
52.60 126
12 Temporal and Spatial Expression of Matrix Metalloproteinases… (10.1111/j.1755-5922.2010.00207.x)
ORCID
52.42 124
13 Nutraceuticals in Diabetes and Metabolic Syndrome (10.1111/j.1755-5922.2010.00179.x)
ORCID
52.07 120
14 Liver X Receptors (LXR) as Therapeutic Targets in Dyslipidem… (10.1111/j.1755-5922.2008.00062.x)
ORCID
51.70 116
15 Targeting Fibrosis for the Treatment of Heart Failure: A Rol… (10.1111/j.1755-5922.2010.00228.x)
ORCID
51.61 115
16 Safety of Herbal Supplements: A Guide for Cardiologists (10.1111/j.1755-5922.2010.00193.x)
ORCID
51.42 113
17 The Cardiovascular Effects of GLP‐1 Receptor Agonists (10.1111/j.1755-5922.2010.00256.x)
ORCID
51.13 110
18 Safety and Feasibility of Levosimendan Administration in Tak… (10.1111/1755-5922.12047)
ORCID
51.03 109
19 Dipeptidyl Peptidase‐4 Inhibitors and Cardiovascular Outcome… (10.1111/1755-5922.12075)
ORCID
50.53 104
20 The Role of Homocysteine‐Lowering B‐Vitamins in the Primary… (10.1111/1755-5922.12064)
ORCID
50.32 102
21 Celiac Disease and Drug Absorption: Implications for Cardiov… (10.1111/1755-5922.12094)
Abstract ORCID
50.00 9
22 Myocardial Reverse Remodeling (10.1111/j.1755-5922.2010.00247.x)
ORCID
49.67 96
23 Assessment of Arterial Stiffness, A Translational Medicine B… (10.1111/j.1755-5922.2008.00051.x)
ORCID
49.21 92
24 Serum Levels of Advanced Glycation End Products (AGEs) are I… (10.1111/j.1755-5922.2010.00177.x)
ORCID
49.21 92
25 Cardio‐Selective Beta‐Blocker: Pharmacological Evidence and… (10.1111/j.1755-5922.2011.00306.x)
ORCID
49.21 92
26 Nebivolol: A Highly Selective β<sub>1</sub>‐Adrenergic Recep… (10.1111/j.1755-5922.2008.00054.x)
ORCID
48.24 84
27 Nutraceuticals and Prevention of Atherosclerosis: Focus on ω… (10.1111/j.1755-5922.2010.00211.x)
ORCID
48.24 84
28 Antibiotic‐induced Cardiac Arrhythmias (10.1111/1755-5922.12054)
ORCID
48.11 83
29 Erectile Dysfunction in High‐Risk Hypertensive Patients Trea… (10.1111/j.1755-5922.2009.00123.x)
ORCID
48.11 83
30 ARIES‐3: Ambrisentan Therapy in a Diverse Population of Pati… (10.1111/j.1755-5922.2011.00279.x)
ORCID
47.58 79
31 Adiponectin, an Unlocking Adipocytokine (10.1111/j.1755-5922.2008.00069.x)
ORCID
47.16 76
32 Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/V… (10.1111/1755-5922.12183)
ORCID
47.02 75
33 Deficiency of a New Protein Associated with Cardiac Syndrome… (10.1111/1755-5922.12025)
ORCID
46.28 70
34 Ginsenoside Re: Pharmacological Effects on Cardiovascular Sy… (10.1111/j.1755-5922.2011.00271.x)
ORCID
46.28 70
35 Diabetes Mellitus and Atrial Remodeling: Mechanisms and Pote… (10.1111/1755-5922.12089)
ORCID
46.13 69
36 Colchicine for prevention and treatment of cardiac diseases:… (10.1111/1755-5922.12226)
ORCID
45.81 67
37 Different Pharmacological Properties of Two Enantiomers in a… (10.1111/j.1527-3466.2008.00044.x)
ORCID
45.81 67
38 Telephone Support to Rural and Remote Patients with Heart Fa… (10.1111/1755-5922.12009)
ORCID
45.49 65
39 Metabolic Syndrome: Bridging the Gap from Childhood to Adult… (10.1111/1755-5922.12165)
ORCID
45.49 65
40 Effects of Quercetin on Gene and Protein Expression of NOX a… (10.1111/j.1755-5922.2009.00071.x)
ORCID
45.49 65
41 RESEARCH: Effects of Long‐Term Disease‐Modifying Antirheumat… (10.1111/j.1755-5922.2009.00119.x)
ORCID
45.49 65
42 Advanced Interatrial Block is Associated with Recurrence of… (10.1111/1755-5922.12063)
ORCID
45.32 64
43 Stimulation of Reactive Oxygen Species and Collagen Synthesi… (10.1111/j.1755-5922.2010.00205.x)
ORCID
45.32 64
44 <scp>GLP</scp>‐1 Receptor Agonists: Effects on Cardiovascula… (10.1111/1755-5922.12000)
ORCID
45.15 63
45 Xanthine Oxidase Inhibition for the Treatment of Cardiovascu… (10.1111/1755-5922.12059)
Abstract ORCID
45.15 7
46 Cilnidipine: A New Generation Ca<sup>2+</sup> Channel Blocke… (10.1111/j.1755-5922.2009.00079.x)
ORCID
45.15 63
47 miR‐30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic… (10.1111/1755-5922.12113)
ORCID
44.81 61
48 The Role of OATP1B1 and BCRP in Pharmacokinetics and DDI of… (10.1111/j.1755-5922.2011.00290.x)
ORCID
44.63 60
49 Hemodynamic Effects, Safety, and Feasibility of Intravenous… (10.1111/1755-5922.12182)
ORCID
44.45 59
50 Effect of fixed‐dose combinations of ezetimibe plus rosuvast… (10.1111/1755-5922.12213)
ORCID
44.45 59